64 results
Page 3 of 4
F-3
zvcqnj79
30 May 14
Shelf registration (foreign)
12:00am
6-K
EX-1.1
brtnk vc1di6928ew
30 May 14
Current report (foreign)
12:00am
424B5
ujyxg eh0h9v0k9
4 Mar 14
Prospectus supplement for primary offering
12:00am
424B5
px2exvld1kffphw fw9
3 Mar 14
Prospectus supplement for primary offering
12:00am
6-K
EX-99.3
otuwze1rg8s3j e9ykp
3 Mar 14
Current report (foreign)
12:00am
424B3
6wr8nucj
8 Aug 13
Prospectus supplement
12:00am
6-K
EX-10.1
t4fm58sr8jh5n
17 May 13
BioLineRx Enters into “At-The-Market” Offering
12:00am
424B5
tqw6q9 975yqnwst
6 Feb 13
Prospectus supplement for primary offering
12:00am
424B3
n2140nadvtli 71
15 Oct 12
Prospectus supplement
12:00am
F-1
8c7ytmn4cgfefnz08jrl
2 Oct 12
Registration statement (foreign)
12:00am
6-K
EX-99
32vu zkvrwxxv28
27 Sep 12
Current report (foreign)
12:00am
424B3
8jfeq4p0
28 Mar 12
Prospectus supplement
12:00am
20-F
p1b2cg
22 Mar 12
Annual report (foreign)
12:00am
6-K
EX-99.2
hj7rwa28f299754sejo6
16 Feb 12
Current Report, Foreign Issuer
12:00am
20FR12B/A
2lzyy6y0i
15 Jul 11
Initial registration of securities (foreign private issuers) (amended)
12:00am
20FR12B
989ts
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
20FR12B
EX-4.13
kdisf8mpk2k03a600b2f
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am